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Chapter 4 
~fETABOLIC STUDIES FOLLOWING 
ORTHOTOPIC LIVER TRAL~SPLANTATION 
THOMAS E. STARZL 
INTRODUCTIO:\" 
I t is not the intention of this chapter to discuss the general field of liver transplantation, but rather a small and fascinat-
ing aspect of this topic. Specifically, it is about the study of 
several normal or abnormal substances that are manufactured 
and released by the liver and which can therefore be used to 
ask important questions about the nature of the liver homograft 
and its function and about liver disease. 
LIVER PROTEIN PHENOTYPES 
The first series of observations concerns the tracing of certain 
proteins. The conclusion is that lirer llOmografts retain their 
metabolic specificity after transfer to a /lew host. This was first 
shown by studies of serum haptoglobin l -! and the group-specific 
component of the alpha globulin fraction3 before and after 
orthotopic liver transplantation in humans. 
The recognition of discrete protein fractions in orthotopic 
liver recipients was made possible by the earlier studies of 
Smithies~ on haptoglobin and of Hirschfeld6 on group-specific 
component. These authors had demonstrated that three kinds 
of haptoglobin and group-specific component were identifiable 
in the human population, that the type present in any indi-
This work was supported by U.S.- Public Health Service grants Nos. AI-AM-
08898, A~I-OlOS9, A~[-12148, AM-06344, A~I-07772, RR-OOOSl, RR-00069, 
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vidual was subject to genetic control, and that the phenotypic 
expression could be detected with electrophoretic techniques. 
In several of our cases of orthotopic.: transplantation, the donors 
have had diHerent haptoglobin and/ or group-specific com-
ponent types than those found in the recipients. \Vithin a few 
hours to a few ~ays after operation, only the donor protein 
fractions were present; the changes were complete and perma-
nent. 
In Figure 4-1 is an example of a change of haptoglobin. 
Preoperatively, the patient had Smithies haptoglobin type 2-1, 
identifiable by the characteristic appearance with starch gel 
electrophoresis. The donor was haptoglobin type 2-2. After 
transplantation only the donor type was detectable in the re-
cipient's sera. The child lived for two and one-half years. 
By immunoelectrophoresis, analogous observations were made 
with group-specific component (Fig. 4-2). Before operation 
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Figure 4-1. EHect of orthotopic liver transplantation on serum haptoglobin 
(H p). The studies were in a patient who preoperatively had Smithies Hp 
type 2-1; her dOll or was Hp type 2-2. After transplantation, ollly the donor 
type was detectable in the recipient sera. The determinations were with 
starch gel electrophoresis. (By permission of W.B. Saunders Co., Experi-
ence ill Hepatic Tranlplalltatioll, 1969.) 
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Figure -1-2. The effect of orthotopic liver transplantation on group specific 
com ponent (Gc). Before operation, the recipient had Gc type 2-1 whereas 
the donor had type 1-1. After transplantation, only the donor type was 
detectable. The recipient, whose original disease was hepatoma, died more 
than 13 months after transplantation, of widespread metastases. The im-
munoelectrophoretic studies were performed with commercial anti-Gc 
antisera. (By permission of \V.B. Saunders Co., Experience in Hepatic 
Transplalltation, 1969.) 
this child had group-specific component type 2-1, whereas the 
donor had type 1-1. After transplantation the recipient's type 
disappeared and only the donor type was thereafter detectable. 
Recently, Alper4 added one of the complement components 
(C'3) to the proteins mentioned whose polymorphism permits 
tracer studies to be carried out from a donor to the recipient. 
A practical implication of these demonstrations is that liver-
based metabolic disorders should be treatable with liver trans-
plantation. The concept has been conclusively tested by Kuster 
et al. of the Mayo Clinic.7 Using mongrel canine liver donors, 
they were able to cure gout naturally present in Dalmatian 
recipients. Conversely, the transplantation of Dalmatian livers 
conferred the defect in uric acid metabolism upon mongrel 
recipients. 
The list of liver-based inborn errors of metabolism is im-
pressive; it ranges from phenylketonuria through certain of the 
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incurable glycogen storage diseases (Type 4 or alpha gl ucosi-
dase deficiency for example). I will not take time to list other 
examples, since there are almost 4 dozen of them, of which 
most are self-evident. Instead, I would like to tell you how 
the kind of research described has been carried one step farther 
and used to try to clarify the etiology of Wilson's disease. 
Wilson's disease is an inborn error of copper metabolism in 
which the essential biochemical feature is the saturation of 
many tissues, including the liver and the brain with copper. 
Copper deposits in the eye result in the characteristic Kayser-
Fleischer rings, by which the clinical diagnosis is often made. 
A serum protein, ceruloplasm, to which copper is attached may 
or may not be deficient in quantity in the peripheral blood. 
Most patients with Wilson's disease can be effectively treated 
with chelating agents such as penicillamine, providing the diag-
nosis is made early enough. 
For many years, controversy has raged about whether or not 
\Vilson's disease is a liver-based inborn error of metabolism. 
Observations with one of our patients may be relevant to at 
least this aspect of the dispute about etiology. An ll-year-old 
child was admitted to our hospital in an agonal state with 
terminal liver failure. The diagnosis of Wilson's disease had 
been considered. Confirmation, however, was missed during the 
preceding 3 years in hospitals from the East to \Vest coasts, 
because of misinterpretation of data, or because of failure in 
one instance to respond to the report of a hepatic biopsy which 
contained all the features of acute 'Vilson's disease, including 
Mallory bodies.~ \Vhen the child was seen, no consideration 
could be given to penicillamine treatment because he was dying. 
Liver replacement was carried out 18 months ago. There 
was an exceedingly severe early rejection which fortunately 
was eventually controlled, after the bilirubin had gone to almost 
50 mgj0 (Fig. 4-3). The child now has completely normal 
function and lives at home. 
After the transplantation, the ceruloplasm in this child has 
been nonnal or even ele,·ated (30 to 55 mg7r). (Normal 
range of ceruloplasm is 22-43 mg7r.) The serum copper has 
been 80 to 170 p.g7c. Postoperati\'ely, there was a major cuprure-
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Figure 4-3. Course after liver replacement. ALG-horse antilymphocyte 
globulin. (By permission of Lancet, 1 :505, 1971.) 
sis which lasted for almost 6 months (Fig. 4-4). Even then, 
there was an additional outpouring of copper in the urine dur-
ing a 3-day course of penicillamine. 
In Wilson's disease, there is often in fact a high copper urine 
excretion, but this is associated with high copper levels in the 
liver. The child had his homograft biopsied 6 and 17 months 
after transplantation. His native liver contained the extraordi-
nary copper level of 216 p.g/ g wet liver tissue, which confirmed 
the diagnosis of Wilson's disease. (Normal range of liver copper 
is 5p.g-20p.g/ gm wet liver tissue.) At 6 months, following the 
chronic cupmresis, the liver copper of the homograft was 15p.g/ g 
and after 17 months it was 13.6p.g (both values normal). Con-
sequently, from these studies we conclude that there has been 
clearance of body copper stores, without accumulation of copper 
in biopsies of the transplanted liver. Further follow-up will be 
necessary before deciding whether the Wilson's disease has 
been cured by liwr replacement and whether this constitutes 
proof that this disorder is an inborn error of hepatic metabolism. 
The observations so far are consistent with these conclusions 
although they do not prove them.9 
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Figure 4-4. Urinary excretion of copper after the orthotopic liver trans-
plantation for Wilson's disease. (By permission of Lancet, 1 :505, 1971.) 
GAMMA GLOBULIN STUDIES 
Thus far, I have pointed out that a liver homograft can and 
does synthesize proteins of new types, thus contributing to the 
internal environment in which the organ must live. The pro-
teins that have been precisely studied (referring again to hap-
toglobin, group-specific component, and C'3 complement) have 
come under such close scrutiny primarily because techniques 
are available for identifying the phenotypes of these proteins. 
While interesting, the fact that protein phenotypes changed 
was not particularly surprising in those instances where there 
was prior evidence that the protein studied was of hepatic 
origin. 
~ow in the second part of this presentation I would like to 
examine the effect of liver transplantation on immunoglobulins, 
and especially gamma G globulin, that have long been thought 
to be exclusively of e:tirahepatic origin. In spite of this, it has 
been found in human recipients of orthotopic livers that im-
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munoglobulin (or Gm) types of donor specificity are regularly 
conferred upon the recipient. I n. II 
At least 21 gamma G globulin phenotypes have been identi-
fied in man. The so-called Gm markers have been used by 
Mathe l :! to determine the success or failure of hone marrow 
transplantation. The standard technique for identification of the 
Gm types is the indirect method of Martensson,I:1 in which the 
patient's serum is added to specific commercial antisera that 
are directed against known Gm types. If that particular Gm 
type is present, it consumes the antiserum, which then fails to 
cause agglutination of a complex antigen (human O-type red 
cells coated with IgG) which serves as an indicator. With ab-
sence of the Gm type being looked for, the antiserum is not 
consumed, and there is agglutination in the indicator system. 
The Gm investigations were carried out by Dr. Nohoru 
Kashiwagjlo.ll on a number of recipients of orthotopic liver 
homografts. In his shtdies, .3 of the Gm types (1,2, and 12) were 
looked for. Initially, it was found that after operation all Gm types 
became transiently positive whether or not these had been 
present previously either in the donor or the recipient. This 
indiscriminate conversion of Gm types was apparently due to 
the multiple blood transfusions which all these patients received 
in the course of their operations. 
In subsequent patients, quantitative studies of the Gm types 
were made. The most interesting cases were those in which 
Gm types were represented in the donor but not the recipient. 
After operation, significant quantities of the donor-specific Gm 
types were conferred upon the recipient. These persisted for 
as long as the first post-transplantation year. In some cases 
there was a slow dying away of the new Gm type over a period 
of many months, but this was never complete. In other in-
stances the new Gm type was fully maintained without loss 
of strength. Whatever Gm types were previously present in 
the recipient were maintained throughout the period of study, 
although the strength of these also sometimes tended to decrease. 
The conclusion from these studies was that the preexisting 
Gm types of the recipients were not altered by transplantation, 
a finding that supports the long held concept that immuno-
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globulin production is not hepatic dependent. However, the 
results also showed that the liver could introduce and support 
a new Gm type not previously present in a given patient. Thus, 
the circulating IgG in the patients was of both donor and re-
cipient origin. There were no easily detectable specific adverse 
consequences in these cases of hewing a genetical1y heterogenous 
admixture of immunoglobulins. 
Special studies, however, were carried out to examine the 
possibility of an interaction between the immunoglobulins of 
host and graft origin. Antigamma globulin antibodies, which 
collectively have been termed rheumatoid factors, were studied 
quantitatively after 3 transplantations. In two patients rheuma-
toid factor titers increased enormously, to as high as 1: 1000 
and 1: 512 after 3 and 5 months. These host gamma M anti-
bodies were shown to be specifically directed against the new 
Gm types that had been introduced into the recipient circu-
lation as a consequence of the transplantation. 
From these data it appeared certain that the new livers were 
responsible in some way for the new immunoglobulin types. At 
this point, the unanswered question was how it had occurred, 
since it was not believed that the homograft hepatocytes were 
responsible for IgG synthesis. One hypothesis might have been 
that the reticuloendothelial cells of the grafts were responsible 
by differentiation into lymphoid cells of donor genotype. To 
investigate this possibility, 9 lh'ers donated by males to female 
recipients were studied by Dr. K.A. Porter14 of London 
(Table 4-1). In the specimens obtained before 100 days, the 
Kupffer cells remained male. After this time, the Kupffer cells 
were female with typical nuclear Barr bodies, and therefore 
of host origin. At the same time the endothelial cells of the 
hepatic arteries and portal veins had not changed sex and did 
not do so for as long as one postoperative year. 
The findings just described disproved the idea that Kupffer 
cells were responsible for new Gm types, since in order to be 
a candidate for a new gamma globulin source it would have 
been necessary for the graft Kupffer cells to retain their donor 
sex identity. An alternative hypothesis to explain the new Gm 
types in these patients was that lymphoid tissue of donor origin 
Patient OT 
Number 
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TABLE !-l 
.\~ALYSIS OF SEX OF CELLS 
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Sex Challge in Graft (.Hale to Female) 
Days Graft 
Residence Kupffrr C,,/ls E IIdol/"'l i al Cells 
~3 :\0 :\0 
400 Yes :\0 
105 Yes :\0 
380 Yes :\0 
35 :\0 :\0 
4 :\0 :\0 
IN :\0 :\0 
IN :\0 :\0 
11 :\0 :\0 
Analysis of the sex of the Kuplfer and vascular endothelial cells in nine patients 
in whom orthotopic livers were transplanted from male dOllors to female recipients. 
had been accidentally carried with the liver homografts. Con-
sequently, a special search was made by Dr. Porter for lymphoid 
tissue in 12 human homografts. Lymphoid deposits were found 
in each case, 1l,H containing prominent lymphoid follicles, promi-
nent germinal centers, and many plasma cells. 
In summary of the second portion of this presentation, new 
Gm types of donor origin were conferred upon recipients of 
orthotopic liver homografts, without altering the previously 
present recipient Gm types. The source of the new Gm types 
was apparently lymphoid tissue transplanted along with the 
liver homo grafts. As an incidental finding in this study, it was 
shown that the Kupffer system of the homo grafts ultimately 
changed and became made up of host cells. The same trans-
formation could not be shown by sexing techniques to have 
occurred in the vascular endothelium. 
ABNORMAL SUBSTANCES 
Two hits of miscellaneous information follow that .might be 
of special interest to those concerned with hepatology. 
Fetoglobulin 
The first is the measurement of alpha fetoprotein as a means 
of following the course of patients being treated for hepatoma. 
The work described was carried out by Dr. Eliott Alpert and 
92 Intermediary Metabolism of the Liver 
Dr. Kurt Isselbacher of Boston on serial samples collected in 
Denver from recipients whose indication for liver replacement 
was hepatoma. 
In patients who developed clinically obvious metastases after 
liver replacement, the fetoprotein was always positive. In these 
cases, there was little need for the fetoprotein determination 
except as a matter of interest. However, in two of our patients, 
the presence of fetoprotein clearly indicated that there was 
persistent tumor, although this could not be detected by other 
diagnostic tests. Conversely, we have followed a child whose 
fetoglobulin serum concentrations fell to zero after orthotopic 
transplantation. We believe that the complete disappearance 
of this primitive protein from the peripheral blood is an indi-
cation of a cure. The child is now more than a year postopera-
tive with perfect liver function and with no eddence of re-
current malignant disease. 
The Australia Antigen Marker 
The second piece of miscellaneous information in this section 
is in the nature of a case report. On August 9, 1970, we re-
moved the liver of a 28··year-old woman who was dying of 
chronic aggres~i\'e hepatitis. She was referred to us by Dr. Alan 
Rediker of Los Angeles who knew that she had Australia anti-
genemia for more than one preceding year. She had a history 
of acute serum hepatitis in 1965. 
During the orthotopic liver transplantation, samples of her 
peripheral venous blood were obtained every 15 minutes. All 
of these contained the Au antigen until her native liver was 
excluded from the circulation and removed. Then, within 15 
minutes, the Australia antigen disappeared (Fig. 4-5) as mea-
sured by a battery of tests ranging from the insensitive Ouch-
terlony immunodiffusion (AG), the more sensitive immuno-
electro-osmophoresis (IEOP), and the highly sensitive com-
plement fixation (CF), to the anticomplementary activity (ACA) 
titers as recently described to be an indication of antigen-anti-
body complexes by Shulman and Barker.Ii> 
She remained Au negative for about 6 weeks and then had a 
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Figure 4-5, The course of a patient who was terminally ill with chronic aggressive 
hepatitis, Australia (Au) antigen positive. She was treated by liver replacement. Note 
that all serologic evidence of serum hepatitis disappeared immediately after operation 
only to return some weeks later. AG-agarose gel micro-Ouchterlony test for Au antigen. 
lEOP-quantitative immunoelectro-osmophoresis test for Au antigen. CF -complement 
fixation test for Au '1ntigen. ACA-anticomplementary activity which is thought to re-
Rect the presence of circulating antigen-antibody complexes; the test is not immuno-
logically specific for Au antigen. 1\Olmal Bessey-Lowry (B-L) units for alkaline phos-
phatase are less than 3. 
return of the Au marker. About 10 days after the reappearance 
of the Au antigen, she developed hepatitis of her hepatic homo-
graft. The clinical course of her new disease was somewhat pro-
longed, about 2 months. Now she has largely recovered, but with 
chronic Au antigenemia just as she had previously (Fig. 4--5). 
She is now 6 months post-transplantation. 
From the study of this patient, we have reached three con-
clusions. First, the treatment of people dying of viral hepatitis 
by liver replacement may be justified on an experimental basis, 
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since this woman's life has been significantly prolonged. Second, 
the liver in patients with chronic aggressive hepatitis appears 
to be the major reservoir from which the Au antigen emanates. 
Third, the incubation period of serum hepatitis, which is cus-
tomarily thought of in terms of the host immunologic apparatus 
and its response, must be viewed in this case as a latent period 
intrinsic to the target organ, the liver. There will be other im-
portant observations from this kind of patient, but these will 
require further periods of followup. 
SUMMARY 
A series of observations were presented about different kinds 
of normal or abnormal substances that come from liver homo-
grafts and that appear in the peripheral blood. These markers 
can be and have been used to study several aspects of hepatic 
physiology and disease. 
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